Cidara Therapeutics Inc (NASDAQ: CDTX) is 15.87% higher on its value in year-to-date trading and has touched a low of $0.59 and a high of $1.48 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CDTX stock was last observed hovering at around $0.84 in the last trading session, with the day’s gains setting it 0.08%.
Currently trading at $0.92, the stock is 28.53% and 31.13% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.51 million and changing 9.25% at the moment leaves the stock 7.43% off its SMA200. CDTX registered -22.69% loss for a year compared to 6-month loss of -5.16%. The firm has a 50-day simple moving average (SMA 50) of $0.69 and a 200-day simple moving average (SMA200) of -$1.28.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 27.74% gain in the last 1 month and extending the period to 3 months gives it a 15.29%, and is 14.56% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.95% over the week and 7.13% over the month.
Profit margin for the company is -55.49%. Distance from 52-week low is 55.14% and -37.84% from its 52-week high. The company has generated returns on investments over the last 12 months (-276.57%).
Cidara Therapeutics Inc quarterly earnings per share for the current quarter are estimated at -$0.1 with sales reaching $11.54M over the same period.The EPS is expected to shrink by -141.07% this year, but quarterly earnings will post -10.00% year-over-year. Quarterly sales are estimated to grow 12.90% in year-over-year returns.
Cidara Therapeutics Inc (CDTX) Top Institutional Holders
56 institutions hold shares in Cidara Therapeutics Inc (CDTX), with institutional investors hold 33.42% of the company’s shares. The shares outstanding are 90.62M, and float is at 81.35M with Short Float at 0.22%. Institutions hold 30.91% of the Float.
The top institutional shareholder in the company is BVF Inc. with over 6.86 million shares valued at $7.75 million. The investor’s holdings represent 7.60% of the CDTX Shares outstanding. As of Jun 29, 2023, the second largest holder is Nantahala Capital Management, LLC with 3.96 million shares valued at $4.48 million to account for 4.39% of the shares outstanding. The other top investors are Vanguard Group Inc which holds 3.21 million shares representing 3.55% and valued at over $3.62 million, while Alethea Capital Management, LLC holds 1.80% of the shares totaling 1.63 million with a market value of $1.84 million.
Cidara Therapeutics Inc (CDTX) Insider Activity
The most recent transaction is an insider sale by Tari Leslie,the company’sCHIEF SCIENTIFIC OFFICER. SEC filings show that Tari Leslie sold 21,029 shares of the company’s common stock on Mar 11 ’24 at a price of $0.67 per share for a total of $14085.0. Following the sale, the insider now owns 0.26 million shares.
Cidara Therapeutics Inc disclosed in a document filed with the SEC on Mar 11 ’24 that Sandison Taylor (Chief Medical Officer) sold a total of 20,662 shares of the company’s common stock. The trade occurred on Mar 11 ’24 and was made at $0.67 per share for $13839.0. Following the transaction, the insider now directly holds 0.35 million shares of the CDTX stock.
Still, SEC filings show that on Mar 11 ’24, Ward Shane (COO & CLO) disposed off 20,473 shares at an average price of $0.67 for $13713.0. The insider now directly holds 198,770 shares of Cidara Therapeutics Inc (CDTX).
